Search alternatives:
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
shape decrease » shape increases (Expand Search), small decrease (Expand Search), step decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
121
The body weight and cholesterol levels of the mice were recorded before the administration of the drug.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
122
The trends of cholesterol metabolism-related gene expression in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
123
-
124
-
125
The Fibrosis scoring by Sirius Red staining and SHG/TPEF.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
126
Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3).
Published 2025Subjects: “…attenuates fibrosis progression…”
-
127
After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
128
-
129
The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
130
Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603...
Published 2025Subjects: “…attenuates fibrosis progression…”
-
131
Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine...
Published 2025Subjects: “…attenuates fibrosis progression…”
-
132
-
133
General procedure for the synthesis of Kylo-0603.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
134
Presentation 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.pptx
Published 2025“…In 14-day UUO mice, renal immunohistochemistry (IHC) showed significantly reduced BDNF expression (P < 0.001), which was further validated by Western blot analysis demonstrating a progressive decline in BDNF protein levels from day 14 to day 21 post-obstruction. …”
-
135
-
136
-
137
-
138
-
139
-
140